Sequoia Genetics

Sequoia Genetics is a newly established, private contract research organization (CRO) specializing in human genetics for drug development. The company offers a service-based model, utilizing its team's deep academic and industry expertise to analyze genetic datasets and generate evidence on target validity, patient stratification, and clinical development pathways. Its value proposition centers on improving the probability of clinical success for its clients' therapeutic programs through rigorous genetic epidemiology and bioinformatics. While pre-revenue and in an early build-out phase, the company is positioned to capitalize on the growing demand for genetic validation in the pharmaceutical R&D pipeline.

Integrated expertise in genetic epidemiology, Mendelian randomization, multi-omics data integration, bioinformatics, and AI/ML applied to human genetic datasets to generate insights for drug development.

Sequoia Genetics competes with large contract research organizations (CROs) offering genomics services, specialized genetics analytics firms (e.g., Genomics plc), and academic consulting groups. Differentiation is based on the specific methodological expertise, publication record, and translational focus of its senior team.